Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
- 14 August 2012
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 126 (7), 860-865
- https://doi.org/10.1161/circulationaha.111.060061
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest, 2012
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort studyEuropean Heart Journal, 2012
- The role of aspirin for stroke prevention in atrial fibrillationNature Reviews Cardiology, 2011
- Validation of the CHADS2 clinical prediction rule to predict ischaemic strokeThrombosis and Haemostasis, 2011
- Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications for ThromboprophylaxisJournal of the American College of Cardiology, 2010
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?Thrombosis and Haemostasis, 2010
- Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial FibrillationStroke, 2008
- Independent predictors of stroke in patients with atrial fibrillationNeurology, 2007
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001